CIB1 is a regulator of pathological cardiac hypertrophy

Nature Medicine

Volumn 16, Issue 8, 2010, Pages 872-879

  Heineke, Joerg ^a,b   Auger Messier, Mannix ^a   Correll, Robert N ^a   Xu, Jian ^a   Benard, Matthew J ^a   Yuan, Weiping ^c   Drexler, Helmut ^b   Parise, Leslie V ^c   Molkentin, Jeffery D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN B; CALCIUM CHANNEL L TYPE; CALCIUM ION AND INTEGRIN BINDING PROTEIN 1; MEMBRANE PROTEIN; PPP3CB PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FORCED SWIMMING TEST; GENE DELETION; GENE OVEREXPRESSION; HEART DISEASE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SARCOLEMMA; SCREENING; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM;

ANIMALS; ANIMALS, NEWBORN; CALCINEURIN; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; CELLS, CULTURED; EMBRYO, MAMMALIAN; HEART; HUMANS; MICE; MICE, TRANSGENIC; MYOCARDIUM; PROTEIN BINDING; RATS; SARCOLEMMA;

MUS; MUS MUSCULUS;

EID: 77955412415     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2181     Document Type: Article

References (48)

1. Rosamond, W. et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25-e146 (2008).
2. Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B. & Ho, K.K. The progression from hypertension to congestive heart failure. J. Am. Med. Assoc. 275, 1557-1562 (1996). (Pubitemid 26154241)
3. Heineke, J. & Molkentin, J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600 (2006).
4. Bueno, O.F., van Rooij, E., Molkentin, J.D., Doevendans, P.A. & De Windt, L.J. Calcineurin and hypertrophic heart disease: novel insights and remaining questions. Cardiovasc. Res. 53, 806-821 (2002).
5. Buch, M.H. et al. The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J. Biol. Chem. 280, 29479-29487 (2005).
6. Frey, N., Richardson, J.A. & Olson, E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 97, 14632-14637 (2000).
7. Heineke, J. et al. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. Proc. Natl. Acad. Sci. USA 102, 1655-1660 (2005).
8. Jeong, D. et al. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Circ. Res. 102, 711-719 (2008).
9. Politino, M. & King, M.M. Calcineurin-phospholipid interactions. Identification of the phospholipid-binding subunit and analyses of a two-stage binding process. J. Biol. Chem. 265, 7619-7622 (1990).
10. Tandan, S. et al. Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel. Circ. Res. 105, 51-60 (2009).
11. Saito, T. et al. Structure, expression profile, and chromosomal location of a mouse gene homologous to human DNA-PKcs interacting protein (KIP) gene. Mamm. Genome 10, 315-317 (1999). (Pubitemid 29390524)
12. Shock, D.D. et al. Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem. J. 342, 729-735 (1999).
13. Stabler, S.M., Ostrowski, L.L., Janicki, S.M. & Monteiro, M.J. A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. J. Cell Biol. 145, 1277-1292 (1999).
14. Gentry, H.R. et al. Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins. J. Biol. Chem. 280, 8407-8415 (2005).
15. Naik, M.U. & Naik, U.P. Calcium-and integrin-binding protein regulates focal adhesion kinase activity during platelet spreading on immobilized fibrinogen. Blood 102, 3629-3636 (2003).
16. Haataja, L., Kaartinen, V., Groffen, J. & Heisterkamp, N. The small GTPase Rac3 interacts with the integrin-binding protein CIB and promotes integrin IIb3-mediated adhesion and spreading. J. Biol. Chem. 277, 8321-8328 (2002).
17. Leisner, T.M., Liu, M., Jaffer, Z.M., Chernoff, J. & Parise, L.V. Essential role of CIB1 in regulating PAK1 activation and cell migration. J. Cell Biol. 170, 465-476 (2005).
18. Naik, U.P., Patel, P.M. & Parise, L.V. Identification of a novel calcium-binding protein that interacts with the integrin?IIb cytoplasmic domain. J. Biol. Chem. 272, 4651-4654 (1997).
19. Jarman, K.E., Moretti, P.A., Zebol, J.R. & Pitson, S.M. Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium and integrin binding protein 1. J. Biol. Chem. 285, 483-492 (2010).
20. Yuan, W. et al. CIB1 is essential for mouse spermatogenesis. Mol. Cell. Biol. 26, 8507-8514 (2006).
21. Zayed, M.A. et al. CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesis. Circ. Res. 101, 1185-1193 (2007).
22. Sanbe, A. et al. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ. Res. 92, 609-616 (2003).
23. Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998).
24. Bueno, O.F. et al. Impaired cardiac hypertrophic response in calcineurin A?-deficient mice. Proc. Natl. Acad. Sci. USA 99, 4586-4591 (2002).
25. Häger, M. et al. Cib2 binds integrin 7b1d and is reduced in laminin?2 chaindeficient muscular dystrophy. J. Biol. Chem. 283, 24760-24769 (2008).
26. Zhu, J., Stabler, S.M., Ames, J.B., Baskakov, I. & Monteiro, M.J. Calcium binding sequences in calmyrin regulates interaction with presenilin-2. Exp. Cell Res. 300, 440-454 (2004).
27. Frey, N., Katus, H.A., Olson, E.N. & Hill, J.A. Hypertrophy of the heart: a new therapeutic target? Circulation 109, 1580-1589 (2004).
28. DeBosch, B. et al. Akt1 is required for physiological cardiac growth. Circulation 113, 2097-2104 (2006).
29. Brancaccio, M. et al. Melusin, a muscle-specific integrin?1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat. Med. 9, 68-75 (2003).
30. Parsons, S.A. et al. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J. Biol. Chem. 279, 26192-26200 (2004).
31. Bourajjaj, M. et al. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J. Biol. Chem. 283, 22295-22303 (2008).
32. Wilkins, B.J. et al. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol. Cell. Biol. 22, 7603-7613 (2002).
33. Li, W. & Handschumacher, R.E. Identification of two calcineurin B-binding proteins: tubulin and heat shock protein 60. Biochim. Biophys. Acta 1599, 72-81 (2002).
34. Politino, M. & King, M.M. Calcium-and calmodulin-sensitive interactions of calcineurin with phospholipids. J. Biol. Chem. 262, 10109-10113 (1987).
35. Iida, T., Egusa, H., Saeki, M., Yatani, H. & Kamisaki, Y. PICK1 binds to calcineurin B and modulates the NFAT activity in PC12 cells. Biochem. Biophys. Res. Commun. 375, 655-659 (2008).
36. Wilkins, B.J. et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94, 110-118 (2004).
37. Heineke, J. et al. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy. Circulation 107, 1424-1432 (2003).
38. Lim, H.W. et al. Calcineurin expression, activation and function in cardiac pressureoverload hypertrophy. Circulation 101, 2431-2437 (2000).
39. Parsons, S.A., Millay, D.P., Sargent, M.A., McNally, E.M. & Molkentin, J.D. Agedependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am. J. Pathol. 168, 1975-1985 (2006).
40. Hilfiker-Kleiner, D. et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128, 589-600 (2007).
41. Haq, S. et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670-677 (2001).
42. Liu, Q., Wilkins, B.J., Lee, Y.J., Ichijo, H. & Molkentin, J.D. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth. Mol. Cell. Biol. 26, 3785-3797 (2006).
43. Vila-Carriles, W.H., Zhou, Z.H., Bubien, J.K., Fuller, C.M. & Benos, D.J. Participation of the chaperone Hsc70 in the trafficking and functional expression of ASIC2 in glioma cells. J. Biol. Chem. 282, 34381-34391 (2007).
44. Jernigan, N.L. et al. Dietary salt enhances benzamil-sensitive component of myogenic constriction in mesenteric arteries. Am. J. Physiol. Heart Circ. Physiol. 294, H409-H420 (2008).
45. Kabaeva, Z., Zhao, M. & Michele, D.E. Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression. Am. J. Physiol. Heart Circ. Physiol. 294, H1667-H1674 (2008).
46. Baines, C.P., Kaiser, R.A., Sheiko, T., Craigen, W.J. & Molkentin, J.D. Voltagedependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9, 550-555 (2007).
47. Neilson, J.R., Winslow, M.M., Hur, E.M. & Crabtree, G.R. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 20, 255-266 (2004).
48. Oka, T. et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation and myocyte viability. Circ. Res. 98, 837-845 (2006).